Literature DB >> 22550155

Human genome-wide association and mouse knockout approaches identify platelet supervillin as an inhibitor of thrombus formation under shear stress.

Leonard C Edelstein1, Elizabeth J Luna, Ian B Gibson, Molly Bray, Ying Jin, Altaf Kondkar, Srikanth Nagalla, Nacima Hadjout-Rabi, Tara C Smith, Daniel Covarrubias, Stephen N Jones, Firdos Ahmad, Moritz Stolla, Xianguo Kong, Zhiyou Fang, Wolfgang Bergmeier, Chad Shaw, Suzanne M Leal, Paul F Bray.   

Abstract

BACKGROUND: High shear force critically regulates platelet adhesion and thrombus formation during ischemic vascular events. To identify genetic factors that influence platelet thrombus formation under high shear stress, we performed a genome-wide association study and confirmatory experiments in human and animal platelets. METHODS AND
RESULTS: Closure times in the shear-dependent platelet function analyzer (PFA)-100 were measured on healthy, nondiabetic European Americans (n=125) and blacks (n=116). A genome-wide association (P<5×10(-8)) was identified with 2 single-nucleotide polymorphisms within the SVIL gene (chromosome 10p11.23) in African Americans but not European Americans. Microarray analyses of human platelet RNA demonstrated the presence of SVIL isoform 1 (supervillin) but not muscle-specific isoforms 2 and 3 (archvillin, SmAV). SVIL mRNA levels were associated with SVIL genotypes (P≤0.02) and were inversely correlated with PFA-100 closure times (P<0.04) and platelet volume (P<0.02). Leukocyte-depleted platelets contained abundant levels of the ≈205-kDa supervillin polypeptide. To assess functionality, mice lacking platelet supervillin were generated and back-crossed onto a C57BL/6 background. Compared with controls, murine platelets lacking supervillin were larger by flow cytometry and confocal microscopy and exhibited enhanced platelet thrombus formation under high-shear but not low-shear conditions.
CONCLUSIONS: We show for the first time that (1) platelets contain supervillin; (2) platelet thrombus formation in the PFA-100 is associated with human SVIL variants and low SVIL expression; and (3) murine platelets lacking supervillin exhibit enhanced platelet thrombus formation at high shear stress. These data are consistent with an inhibitory role for supervillin in platelet adhesion and arterial thrombosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22550155      PMCID: PMC3515852          DOI: 10.1161/CIRCULATIONAHA.112.091462

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  45 in total

Review 1.  Platelets in atherothrombosis.

Authors:  Zaverio M Ruggeri
Journal:  Nat Med       Date:  2002-11       Impact factor: 53.440

2.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

3.  Monitoring of antiplatelet therapy with the PFA-100 in peripheral angioplasty patients.

Authors:  S Ziegler; T Maca; E Alt; W Speiser; B Schneider; E Minar
Journal:  Platelets       Date:  2002-12       Impact factor: 3.862

4.  Changes in the cytoskeletal structure of human platelets following thrombin activation.

Authors:  L K Jennings; J E Fox; H H Edwards; D R Phillips
Journal:  J Biol Chem       Date:  1981-07-10       Impact factor: 5.157

5.  Platelet PECAM-1 inhibits thrombus formation in vivo.

Authors:  Shahrokh Falati; Sonali Patil; Peter L Gross; Michelle Stapleton; Glenn Merrill-Skoloff; Natasha E Barrett; Katherine L Pixton; Harmut Weiler; Brian Cooley; Debra K Newman; Peter J Newman; Barbara C Furie; Bruce Furie; Jonathan M Gibbins
Journal:  Blood       Date:  2005-09-15       Impact factor: 22.113

Review 6.  New insights into the biology of Wiskott-Aldrich syndrome (WAS).

Authors:  Adrian J Thrasher
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

7.  Platelet function predicts myocardial damage in patients with acute myocardial infarction.

Authors:  Martin Frossard; Ingrid Fuchs; Judith M Leitner; Kety Hsieh; Marianne Vlcek; Heidrun Losert; Hans Domanovits; Wolfgang Schreiber; Anton N Laggner; Bernd Jilma
Journal:  Circulation       Date:  2004-08-16       Impact factor: 29.690

8.  F-actin and myosin II binding domains in supervillin.

Authors:  Yu Chen; Norio Takizawa; Jessica L Crowley; Sang W Oh; Cheryl L Gatto; Taketoshi Kambara; Osamu Sato; Xiang-Dong Li; Mitsuo Ikebe; Elizabeth J Luna
Journal:  J Biol Chem       Date:  2003-08-12       Impact factor: 5.157

9.  VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA.

Authors:  A A Kondkar; M S Bray; S M Leal; S Nagalla; D J Liu; Y Jin; J F Dong; Q Ren; S W Whiteheart; C Shaw; P F Bray
Journal:  J Thromb Haemost       Date:  2009-11-23       Impact factor: 5.824

10.  Genetic susceptibility to death from coronary heart disease in a study of twins.

Authors:  M E Marenberg; N Risch; L F Berkman; B Floderus; U de Faire
Journal:  N Engl J Med       Date:  1994-04-14       Impact factor: 91.245

View more
  15 in total

1.  Replication and hematological characterization of human platelet reactivity genetic associations in men from the Caerphilly Prospective Study (CaPS).

Authors:  John D Eicher; Luting Xue; Yoav Ben-Shlomo; Andrew D Beswick; Andrew D Johnson
Journal:  J Thromb Thrombolysis       Date:  2016-02       Impact factor: 2.300

2.  The pharmacoepigenomics informatics pipeline defines a pathway of novel and known warfarin pharmacogenomics variants.

Authors:  Ari Allyn-Feuer; Alex Ade; Jasmine A Luzum; Gerald A Higgins; Brian D Athey
Journal:  Pharmacogenomics       Date:  2018-02-05       Impact factor: 2.533

3.  Whole exome sequencing in the Framingham Heart Study identifies rare variation in HYAL2 that influences platelet aggregation.

Authors:  John D Eicher; Ming-Huei Chen; Achilleas N Pitsillides; Honghuang Lin; Narayanan Veeraraghavan; Jennifer A Brody; Ginger A Metcalf; Donna M Muzny; Richard A Gibbs; Diane M Becker; Lewis C Becker; Nauder Faraday; Rasika A Mathias; Lisa R Yanek; Eric Boerwinkle; L Adrienne Cupples; Andrew D Johnson
Journal:  Thromb Haemost       Date:  2017-03-16       Impact factor: 5.249

4.  Supervillin binds the Rac/Rho-GEF Trio and increases Trio-mediated Rac1 activation.

Authors:  Kyonghee Son; Tara C Smith; Elizabeth J Luna
Journal:  Cytoskeleton (Hoboken)       Date:  2015-02-28

5.  Gamma-sarcoglycan is required for the response of archvillin to mechanical stimulation in skeletal muscle.

Authors:  Janelle M Spinazzola; Tara C Smith; Min Liu; Elizabeth J Luna; Elisabeth R Barton
Journal:  Hum Mol Genet       Date:  2015-01-20       Impact factor: 6.150

6.  Supervillin-mediated suppression of p53 protein enhances cell survival.

Authors:  Zhiyou Fang; Elizabeth J Luna
Journal:  J Biol Chem       Date:  2013-02-04       Impact factor: 5.157

7.  An N-terminal, 830 residues intrinsically disordered region of the cytoskeleton-regulatory protein supervillin contains Myosin II- and F-actin-binding sites.

Authors:  Stanislav O Fedechkin; Jacob Brockerman; Elizabeth J Luna; Michail Yu Lobanov; Oxana V Galzitskaya; Serge L Smirnov
Journal:  J Biomol Struct Dyn       Date:  2012-10-17

8.  Phosphoproteomic analysis of platelets activated by pro-thrombotic oxidized phospholipids and thrombin.

Authors:  Alejandro Zimman; Bjoern Titz; Evangelia Komisopoulou; Sudipta Biswas; Thomas G Graeber; Eugene A Podrez
Journal:  PLoS One       Date:  2014-01-06       Impact factor: 3.240

9.  The complex transcriptional landscape of the anucleate human platelet.

Authors:  Paul F Bray; Steven E McKenzie; Leonard C Edelstein; Srikanth Nagalla; Kathleen Delgrosso; Adam Ertel; Joan Kupper; Yi Jing; Eric Londin; Phillipe Loher; Huang-Wen Chen; Paolo Fortina; Isidore Rigoutsos
Journal:  BMC Genomics       Date:  2013-01-16       Impact factor: 3.969

10.  Genomic architecture of sickle cell disease in West African children.

Authors:  Jacklyn Quinlan; Youssef Idaghdour; Jean-Philippe Goulet; Elias Gbeha; Thibault de Malliard; Vanessa Bruat; Jean-Christophe Grenier; Selma Gomez; Ambaliou Sanni; Mohamed C Rahimy; Philip Awadalla
Journal:  Front Genet       Date:  2014-02-14       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.